Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CRISPRjournal
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CRISPRjournal
-
The CRISPR Journal proslijedio/la je Tweet
Exciting! 1. No humoral responses to Cas9 detected, 2. Chromosomal translocations with triple KO detected but decreases over time (no apparent growth adv), 3. Long term engraftment - avg half life of T cells is 84 days vs 1 wk with previous engineered NYESO T cellshttps://twitter.com/sciencemagazine/status/1225517039080681473 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
@CRISPRjournal Editor Dr. Kevin Davies will be attending the upcoming@KeystoneSymp "Engineering the Genome" meeting, starting this weekend in Banff, Canada, and shares his insights about the field, and the program on our latest Keypoint blog: https://keypoint.keystonesymposia.org/features/crispr-journals-kevin-davies-attend-genome-engineering-meeting/ …#KSgenomepic.twitter.com/U29SqVOwVR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
June Lab Delivers CRISPR Safety Message in Cancer Clinical Trial -- by our colleagues
@genbiohttps://www.genengnews.com/insights/june-lab-delivers-crispr-safety-message-in-cancer-clinical-trial/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
Carl June was the PI on the first gene editing trial, in 2009, and continues to lead in essential ways. Key findings from this trial at Penn will inform, enhance, and accelerate gene editing trials in cancer and beyond.
@carlhjunehttps://www.sciencemag.org/news/2020/02/cutting-edge-crispr-gene-editing-appears-safe-three-cancer-patients …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
Base-editing genetic medicines company BEAM to IPO today; raising $180M, $17/share Leadership of
@john_evans3 clearly a key ingredient to success so far.
Kudos to founders @davidrliu@zhangf@JKeithJounghttps://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-announces-pricing-initial-public-offering/ …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
It makes me feel a bit vulnerable to have this all out there, but here it is: my scientific life story! Very happy and grateful to be where I am
@igiscihttps://twitter.com/benchling/status/1225133496554881024 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
We are looking for a colleague to start their own research group in the beautiful and inspiring environment of Delft. Please RT https://www.nature.com/naturecareers/job/assistant-professor-tenure-track-position-in-bionanoscience-delft-university-of-technology-tu-delft-718739 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
Thanks to
@GENbio for highlighting@SentiBio's gene circuits platform for next-generation cell and gene therapies. We can create more efficacious and safer medicines through sophisticated genetic engineering.https://twitter.com/SentiBio/status/1224782308936318976 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
The CRISPR Journal proslijedio/la je Tweet
CALL FOR PAPERS! Special issue: "Applications of Next Generation CRISPR-derived Technologies" https://home.liebertpub.com/cfp/applications-ofandnbspnext-generation-crispr-derived-technol/220/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
Naive question to CRISPR/Anti-CRISPR people: Are there some bacteria-encoded anti-anti-CRISPR proteins already described? Or would it be "easier" for bacteria to just use other anti-phage defense systems instead?
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
Thanks,
@GENbio! "Anchoring the [CRISPR J] issue, Hank Greely..effectively dismantles the argument that the human genome—“the heritage of humanity” as UNESCO calls it—should be kept inviolate." https://www.genengnews.com/insights/guilty-as-charged/ … Also notes I said plausible good uses are rare.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
Her gene-editing tool could cure disease and change the human race. But what happens if it falls into the wrong hands? Jennifer Doudna, Kavli Prize recipient of 2018, talks ethics.https://www.ft.com/content/6d063e48-4359-11ea-abea-0c7a29cd66fe …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
Pleased (and humbled) to announce that I've been appointed to
@theNAMedicine's newly formed Committee on Emerging Science, Technology, and Medicine. Very much looking forward to working with such a distinguished (and friendly) group of scholars. https://nam.edu/programs/committee-on-emerging-science-technology-and-innovation-in-health-and-medicine/committee-roster/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
Re: germline editing debate. The moratorium failed to gain momentum, but initiatives to foster a wider policy debate didn't do better. So reviving the moratorium is fair game, yet
@Nuffbioethics report remains >>> moratorium call IMHO.https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(19)30317-8?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0167779919303178%3Fshowall%3Dtrue …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
The mere claim that such short inserts support nCoV origins "unlikely to be fortuitous in nature" [sic] is already highly suspect. This is a classic case of searching for lost keys only under a lamppost. A fearful world does not need to fuel conspiracy theories with bad analyses.https://twitter.com/SKonermann/status/1223344537772290048 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
Just checked their results. The similarity is spurious. Out of 4 inserts they identify between NCov and SARS, 2 are found in bat coronavirus. Of the remaining two, only one is most similar to HIV, and is so short (6 AA) that the similarity is not higher than chance given database
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Still time to sign up for the first major CRISPR/genome engineering conference of the year!
#KSgenome@KeystoneSymp https://www.keystonesymposia.org/ks/Online/Events/2020Q2/Details.aspx?EventKey=2020Q2 …pic.twitter.com/liHVrlUdwS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je Tweet
1/5 Today, we are proud to announce the publication of the "Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction” in Trends in Biotechnology. https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(19)30317-8 …pic.twitter.com/wp6mGEBCbJ
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The CRISPR Journal proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.